Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries
- 1 February 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 178 (2) , 231-239
- https://doi.org/10.1016/j.atherosclerosis.2004.09.006
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- 17β-Estradiol Increases Nitric Oxide and Prostaglandin I2 Production by Cultured Human Uterine Arteries Only in Histologically Normal SpecimensJournal of Cardiovascular Pharmacology, 2001
- Regulation of Nitric Oxide Production by Arginine Metabolic EnzymesBiochemical and Biophysical Research Communications, 2000
- Biological effects of arginine metabolitesActa Physiologica Scandinavica, 2000
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension, 1994
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.Journal of Clinical Investigation, 1990
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986